Galidesivir
| CAS No. | 249503-25-1 | Cat. No. | BCP19643 |
| Name | Galidesivir | ||
| Synonyms | BCX4430; BCX 4430; BCX-4430; Immucillin-A; | ||
| Formula | C11H15N5O3 | M. Wt | 265.27 |
| Description | Galidesivir, also known as BCX4430 and Immucillin-A, is an antiviral drug and an adenosine analog. Galidesivir was originally intended as a treatment for Hepatitis C, but subsequently developed as a potential treatment for deadly filovirus infections such as Ebola virus disease and Marburg virus disease. Galidesivir also shows broad-spectrum antiviral effectiveness against a range of other RNA virus families, including bunyaviruses, arenaviruses, paramyxoviruses, coronaviruses and flaviviruses. BCX4430 has been demonstrated to protect against both Ebola and Marburg viruses in both rodents and monkeys, even when administered up to 48 hours after infection. | ||
| Pathways | Microbiology/Virology | ||
| Targets | Filovirus | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.